Form D · Pharmaceuticals
KinDex Pharmaceuticals, Inc.
Cambridge, MA · CIK 0001602462
Offering snapshot reported May 14, 2019 · SEC filing
- Reported sold
- $900K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2019 | Initial | $900,000 | No comparison | 6 | SEC filing |
| Jun 27, 2017 | Amendment | $1,054,546 | $727,272vs Aug 30, 2016 | 6 | SEC filing |
| Aug 30, 2016 | Initial | $327,274 | No comparison | 4 | SEC filing |
| Mar 9, 2015 | Amendment | $5,500,000 | $500,000vs Mar 13, 2014 | 6 | SEC filing |
| Mar 13, 2014 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339492
Source: Form D, filed May 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis Ausiello | Director |
| Jeffrey S Bland | Executive |
| Lincoln Bouillon | Executive |
| Roger Colman | Director |
| Brent Eck | Director |
| Neile A Grayson | Executive |
| Michael Higgins | Executive |
| Jeffrey J Katke | Director |
| Paul Schimmel | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
110 Coolidge Hill
Cambridge, MA, 02138
Cambridge, MA, 02138